CMS Open Payments · Program Year 2024
CTL Medical Corporation
CTL Medical Corporation reported $565,324.78 across General Payments, Research, and Ownership to 315 physicians and teaching hospitals across 315 transactions.
- $565.3K
- All-tracks total
- 315
- Transactions
- 315
- Recipients
- −$27.5K
- General Payments vs PY2023
CTL Medical Corporation reported $565,324.78 across all CMS Open Payments tracks (General + Research + Ownership) to 315 physicians and teaching hospitals in Program Year 2024 - ranking #736 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $565,324.78, averaging $1.8K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ctl-medical-corporation CTL Medical Corporation
$565.3K · #736/1,925 · 0.0% industry · PY2024
- TOT $565.3K
- RANK #736
- SHARE 0.0%
- TXN 315
- RCP 315
- CAT 5
- GEN $565.3K
- ΔGEN −$27.5K
- TOP1 14.9%
- PY 2024
Volume peers
Nearest volume peer: Expanding Innovations, Inc. ($566.5K)
CTL Medical Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
CTL Medical Corporation's CMS-reported General Payments decreased by $27.5K (−4.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CTL MEDICAL CORPORATIONPY2023: CTL MEDICAL CORPORATIONPY2024: CTL Medical Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $592,856.31
- PY2024
- $565,324.78
What the Data Shows for CTL Medical Corporation
In Program Year 2024, CTL Medical Corporation reported $565,324.78 in payments to 315 physicians and teaching hospitals across 315 individual transactions, an average of $1.8K per transaction and $1.8K per recipient. That total places CTL Medical Corporation at rank #736 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
96 transactions worth $402.2K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 71.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
CTL Medical Corporation made 5 types of general payments. "Consulting Fee" is the largest category at $402.2K, 71.1% of General Payments.
CTL Medical Corporation reports 5 general-payment categories - the top three are Consulting Fee (71.1%), Royalty or License (23.1%), and Travel and Lodging (3.3%). The remaining 2 categories make up 2.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How CTL Medical Corporation divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $402.2K | 96 | 71.1% |
| Royalty or License | $130.7K | 39 | 23.1% |
| Travel and Lodging | $18.7K | 46 | 3.3% |
| Food and Beverage | $10.8K | 121 | 1.9% |
| Gift | $3.0K | 13 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $300,442.23 (53.1%) of $565,324.78 in this company's General Payments records across 58 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CTL Medical Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Dilip Sengupta
$84,206.81 across 13 reported transactions
- 2
Frederik Anthonius Pennings
$74,193.29 across 14 reported transactions
- 3
Taylor Beatty
$58,099.37 across 22 reported transactions
- 4
Roger P Jackson
$48,942.76 across 4 reported transactions
- 5
Daniel Fahim
$35,000.00 across 7 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CTL Medical Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CTL Medical Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CTL Medical Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Maxx Orthopedics, Inc.
Republic Spine
Perfuze Limited
Hyperfine Operations, Inc.
Aesculap Biologics, LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.